abstract |
The present invention relates to a novel quinazoline derivative compound and a use thereof and, more specifically, to a novel quinazoline derivative compound of the following chemical formula 1 having inhibitory activity against a bromodomain extra-terminal (BET) protein, and a pharmaceutical composition for preventing or treating BET protein-related diseases comprising same. |